NCT03734055

Brief Summary

The Peer Approaches to Lupus Self-Management (PALS) study is a randomized, controlled in which 360 African American women with lupus will be recruited from the MUSC SLE database (60 mentors and 300 mentees). The peer mentoring intervention (patients will be matched with peer mentors who are considered competent in the management of their condition to provide modeling and reinforcement to participants) will occur by telephone for approximately 60 minutes every two weeks for 24 weeks. All participants will be assessed at baseline, mid-intervention (12 weeks post-enrollment), immediately following the intervention (24 weeks post-enrollment), and 12 months post-enrollment. The study will last 60 months with recruitment and enrollment over 48 months, 6 months for intervention delivery and 6 months for data analysis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
314

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Nov 2018Jun 2026

First Submitted

Initial submission to the registry

October 26, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 7, 2018

Completed
23 days until next milestone

Study Start

First participant enrolled

November 30, 2018

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

August 20, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

August 20, 2025

Status Verified

August 1, 2025

Enrollment Period

4.4 years

First QC Date

October 26, 2018

Results QC Date

December 31, 2024

Last Update Submit

August 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Satisfaction in Quality of Life as Assessed by the LUP-QOL (Lupus Quality of Life Questionnaire

    Quality of life will be assessed by using The LUP-QOL (Lupus Quality of Life Questionnaire), which assesses areas of the participant's life that may be affected by lupus. The score ranges from 0-100. A score of '0' indicates the lowest quality of life, and a score of 100 indicates the best quality of life. The 'Overall Impact' field reported has a scale of 0-700. Higher values represent a better outcome.

    Baseline to 12 months post-intervention

  • Change in Self-management

    The Patient Activation Measure (PAM) assesses an individual's knowledge, skill, and confidence for managing their health and healthcare. Individuals who measure high on this assessment typically understand the importance of taking a proactive role in managing their health and have the skills and confidence to do so. The PAM survey measures patients on a 0-100 scale and can segment patients into one of four activation levels along an empirically derived continuum, including "Believes Active Role Important", "Confidence and Knowledge to Take Action", "Taking Action", and "Staying Course Under Stress". Each activation level reveals insight into an array of health-related characteristics, including attitudes, motivators, behaviors, and outcomes. A high score represents a better outcome.

    Baseline to 12 months post-intervention

Secondary Outcomes (3)

  • Treatment Credibility

    Baseline to 12 months post-intervention

  • Satisfaction With Care: Validated General Scale

    Baseline to 12 months post-intervention

  • Disease Activity Measured by the Systemic Lupus Activity Questionnaire (SLAQ)

    Baseline to 12 months post-intervention

Study Arms (3)

Peer Mentoring

EXPERIMENTAL

The program will consist of 12 sessions of peer mentoring that will include one standard educational session by telephone or video for approximately 60 minutes every 2 weeks. Additional interaction will be discouraged, but mentees and mentors will be asked to report any additional social interaction should it occur. The bi-weekly educational session will be generally structured in three parts: introduction, structured education, and problem solving. 60-minute calls are necessary for the delivery of educational content and mentors and mentees to be able to discuss their own experiences and potential solutions.

Behavioral: Peer Mentoring

Social Support Group

ACTIVE COMPARATOR

Mentees randomized to the social support control group will be enrolled in a lupus support group designed specifically for this project.

Behavioral: Social Support Group

Peer Mentors

NO INTERVENTION

The principal roles of the peer mentors are to: 1) provide information about SLE, SLE-related behaviors, thoughts, and feelings, and the nature of recommended treatments; 2) provide social support to alleviate the mentee's sense of social isolation; 3) enhance and reinforce the mentee's sense of self-efficacy to manage their condition; and 4) encourage the mentee to participate actively in the recommended self-management skills building therapy.

Interventions

Peer MentoringBEHAVIORAL

Manualized peer mentorship program designed to provide modeling and reinforcement by peers (mentors) to other African American women with SLE (mentees) to encourage them to engage in activities that promote disease self-management.

Peer Mentoring

Social support controls will participate in a lupus support group created for this project, on the same schedule as peer mentoring sessions.

Social Support Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American race/ethnicity
  • Female sex
  • Clinical diagnosis of SLE from a physician, according to ACR revised criteria for SLE
  • years of age or older
  • Disease duration \> 2 years
  • Able to attend scheduled training sessions
  • Willing to provide one-on-one support to up to three African American women with SLE

You may not qualify if:

  • Mentees who participated in the pilot will be ineligible to participate in this study as a mentee, but could participate as a mentor if they meet other eligibility criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Related Publications (2)

  • Leung J, Keller EP, Nietert P, Caldwell T, Dismuke-Greer CL, Johnson H, Williams E. Does social support reduce bodily pain among African American women with SLE? Findings from a randomised controlled trial. Lupus Sci Med. 2025 Oct 20;12(2):e001712. doi: 10.1136/lupus-2025-001712.

  • Williams EM, Egede L, Oates JC, Dismuke CL, Ramakrishnan V, Faith TD, Johnson H, Rose J. Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial. Trials. 2019 Aug 23;20(1):529. doi: 10.1186/s13063-019-3580-4.

MeSH Terms

Conditions

Lupus Erythematosus, SystemicHealth Behavior

Interventions

Self-Help Groups

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Results Point of Contact

Title
Dr. Edith Williams
Organization
University of Rochester

Study Officials

  • Edith Williams, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2018

First Posted

November 7, 2018

Study Start

November 30, 2018

Primary Completion

April 23, 2023

Study Completion (Estimated)

June 30, 2026

Last Updated

August 20, 2025

Results First Posted

August 20, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

IPD will not be available. All findings will be reported in aggregate terms.

Locations